Acute Myelogenous Leukemia

Showing 51 - 75 of 203

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia Trial in Philadelphia (Birinapant)

Terminated
  • Acute Myelogenous Leukemia
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 23, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +3 more
  • total body irradiation
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 17, 2021

Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

Terminated
  • Acute Myelogenous Leukemia
  • Birmingham, Alabama
  • +16 more
Apr 14, 2021

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • MCLA-117 bispecific antibody
  • Augusta, Georgia
  • +9 more
May 6, 2021

Acute Myelogenous Leukemia Trial in Fuzhou, Shanghai (SH1573 Capsules)

Recruiting
  • Acute Myelogenous Leukemia
  • SH1573 Capsules
  • Fuzhou, Fujian, China
  • +1 more
Mar 17, 2021

Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia Trial in Washington, Bethesda, Oklahoma City

Completed
  • Myelodysplastic Syndrome
  • +4 more
  • First Allogeneic Bone Marrow Transplant (BMT)
  • +9 more
  • Washington, District of Columbia
  • +2 more
Mar 16, 2021

Acute Myelogenous Leukemia Trial in United States (KIR genotype)

Completed
  • Acute Myelogenous Leukemia
  • KIR genotype
  • Scottsdale, Arizona
  • +18 more
Mar 9, 2021

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

Terminated
  • Chronic Myelogenous Leukemia
  • +7 more
  • CD3/CD28 Activated T cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 12, 2020

Acute Myelogenous Leukemia, Allogeneic Stem Cell Transplantation Trial in Ramat Gan (Bisantrene)

Completed
  • Acute Myelogenous Leukemia
  • Allogeneic Stem Cell Transplantation
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Aug 6, 2020

Acute Myelogenous Leukemia, MDS Trial in Petach Tikva, Re?ovot (Nerofe, Doxorubicin)

Withdrawn
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Petach Tikva, Israel
  • +1 more
Jul 29, 2020

Acute Myelogenous Leukemia, MDS, Leukemia Trial in Miami (Tranylcypromine, Tretinoin)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Miami, Florida
    University of Miami
Jul 20, 2020

Acute Myelogenous Leukemia Trial in Chicago, Minneapolis, Columbus (Interventions)

Terminated
  • Acute Myelogenous Leukemia
  • Interventions
  • Chicago, Illinois
  • +2 more
Jul 8, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Tetanus
  • Houston, Texas
  • +1 more
Apr 20, 2020

Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)

Completed
  • Acute Myelogenous Leukemia
  • Brentuximab Vedotin
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 12, 2020

Acute Myelogenous Leukemia Trial in United States (MLN4924, Azacitidine)

Completed
  • Acute Myelogenous Leukemia
  • Birmingham, Alabama
  • +7 more
Feb 18, 2020

MDS, Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Gainesville (Molecular diagnostic testing)

Terminated
  • Myelodysplastic Syndromes
  • +6 more
  • Molecular diagnostic testing
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Dec 18, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Belgium (Donor lymphocyte infusion, Azacytidine)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Antwerpen, Belgium
  • +11 more
Dec 6, 2019

Refractory or Recurrent Solid Tumors, Acute Myelogenous Leukemia Trial in Philadelphia (Cediranib, AZD2171, RECENTIN)

Completed
  • Refractory or Recurrent Solid Tumors
  • Acute Myelogenous Leukemia
  • Cediranib, AZD2171, RECENTIN
  • Philadelphia, Pennsylvania
    Childrens Hospital, Philadelphia
Nov 20, 2019

Acute Myelogenous Leukemia Trial in Greenville (Interleukin-2)

Terminated
  • Acute Myelogenous Leukemia
  • Greenville, North Carolina
    Leo W. Jenkins Cancer Center
Aug 20, 2019